Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), By Mechanism, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                    1.5. Details of Primary Research
                    1.6. Market Formulation & Validation
                    1.7. Region-Wise Market Calculation
                        1.7.1. Region-Wise Market: Base Estimates
                        1.7.2. Global Market: CAGR Calculation
                        1.7.3. Region Based Segment Share Calculation
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis (Model 1)
                            1.8.1.1. Approach 1: Commodity Flow Approach
                        1.8.2. Value Chain-Based Sizing & Forecasting (Model 2)
                        1.8.3. QFD Model Sizing & Forecasting (Model 3)
                        1.8.4. Bottom-up Approach (Model 4)
                    1.9. Research Scope and Assumptions
                    1.10. List of Secondary Sources
                    1.11. List of Primary Sources
                    1.12. List of Abbreviations
                    1.13. Objectives
                        1.13.1. Objective - 1
                        1.13.2. Objective - 2
                        1.13.3. Objective - 3
                        1.13.4. Objective - 4
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Oral Solid Dosage Contract Manufacturing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
                            3.2.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
                            3.2.1.3. Increasing Demand for Novel Therapies
                            3.2.1.4. Increasing Demand for One-Stop-Shop CMOs
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Strict Approval Criteria by Regulatory Authorities
                            3.2.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
                            3.2.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
                    3.3. Oral Solid Dosage Contract Manufacturing Market Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
                    3.4. Technology Landscape
                        3.4.1. Manufacturing Technology
                        3.4.2. Encapsulation Technology
                        3.4.3. Coating Technology
                        3.4.4. Packaging Technology
                        3.4.5. Analytical Technology
                    3.5. COVID-19 Impact Analysis
Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
                    4.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
                    4.4. Tablets
                        4.4.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.2. Compressed Tablets
                            4.4.2.1. Compressed Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.3. Orally Disintegrating Tablets (ODT)
                            4.4.3.1. Orally Disintegrating Tablets (ODT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.4. Chewable Tablets
                            4.4.4.1. Chewable Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.5. Bi-layer or Tri-layer Tablets
                            4.4.5.1. Bi-layer or Tri-layer Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.6. Sublingual or Buccal Tablets
                            4.4.6.1. Sublingual or Buccal Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.7. Others
                            4.4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Capsules
                        4.5.1. Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.2. Hard Gelatin Capsules
                            4.5.2.1. Hard Gelatin Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.3. Soft Gelatin Capsules
                            4.5.3.1. Soft Gelatin Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Powder
                        4.6.1. Powder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Granules
                        4.7.1. Granules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. Others
                        4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
                    5.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
                    5.4. Immediate Release
                        5.4.1. Immediate Release Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Delayed Release
                        5.5.1. Delayed Release Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Controlled Release
                        5.6.1. Controlled Release Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Oral Solid Dosage Contract Manufacturing Market: Service Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Oral Solid Dosage Contract Manufacturing Market: Service Movement Analysis
                    6.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
                    6.4. Drug Product Development
                        6.4.1. Drug Product Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Fill Finish Product Manufacturing
                        6.5.1. Fill Finish Product Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. API Manufacturing
                        6.6.1. API Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Others
                        6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Drug Potency Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Oral Solid Dosage Contract Manufacturing Market: Drug Potency Movement Analysis
                    7.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Drug Potency, 2018 to 2030 (USD Million)
                    7.4. High Potent Drugs
                        7.4.1. High Potent Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Moderate Potent Drugs
                        7.5.1. Moderate Potent Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. Low Potent Drugs
                        7.6.1. Low Potent Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Oral Solid Dosage Contract Manufacturing Market: Prescription Type Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. Oral Solid Dosage Contract Manufacturing Market: Prescription Type Movement Analysis
                    8.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Prescription Type, 2018 to 2030 (USD Million)
                    8.4. Prescription Drugs
                        8.4.1. Prescription Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Over-The-Counter Drugs
                        8.5.1. Over-The-Counter Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Oral Solid Dosage Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis
                    9.1. Segment Dashboard
                    9.2. Oral Solid Dosage Contract Manufacturing Market: Therapeutic Area Movement Analysis
                    9.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
                    9.4. Oncology
                        9.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.5. Cardiovascular Diseases
                        9.5.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.6. Metabolic Disorders
                        9.6.1. Metabolic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.7. Neurological Disorders
                        9.7.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.8. Infectious Diseases
                        9.8.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.9. Gastrointestinal Diseases
                        9.9.1. Gastrointestinal Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.10. Other Therapeutic Areas
                        9.10.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis
                    10.1. Segment Dashboard
                    10.2. Oral Solid Dosage Contract Manufacturing Market: End Use Movement Analysis
                    10.3. Global Oral Solid Dosage Contract Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    10.4. Large Size Companies
                        10.4.1. Large Size Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    10.5. Medium & Small Size Companies
                        10.5.1. Medium & Small Size Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    10.6. Others
                        10.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Oral Solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Product Type, by Mechanism, by Drug Potency, by Service, by Prescription Type, by Therapeutic Area, by End Use
                    11.1. Regional Dashboard
                    11.2. Oral Solid Dosage Contract Manufacturing Market: Regional Movement Analysis
                    11.3. North America
                        11.3.1. North America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.3.2. U.S.
                            11.3.2.1. Key Country Dynamics
                            11.3.2.2. Competitive Scenario
                            11.3.2.3. Regulatory Framework
                            11.3.2.4. U.S. Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.3.3. Canada
                            11.3.3.1. Key Country Dynamics
                            11.3.3.2. Competitive Scenario
                            11.3.3.3. Regulatory Framework
                            11.3.3.4. Canada Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.3.4. Mexico
                            11.3.4.1. Key Country Dynamics
                            11.3.4.2. Competitive Scenario
                            11.3.4.3. Regulatory Framework
                            11.3.4.4. Mexico Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    11.4. Europe
                        11.4.1. Europe Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.2. UK
                            11.4.2.1. Key Country Dynamics
                            11.4.2.2. Competitive Scenario
                            11.4.2.3. Regulatory Framework
                            11.4.2.4. UK Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.3. Germany
                            11.4.3.1. Key Country Dynamics
                            11.4.3.2. Competitive Scenario
                            11.4.3.3. Regulatory Framework
                            11.4.3.4. Germany Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.4. France
                            11.4.4.1. Key Country Dynamics
                            11.4.4.2. Competitive Scenario
                            11.4.4.3. Regulatory Framework
                            11.4.4.4. France Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.5. Italy
                            11.4.5.1. Key Country Dynamics
                            11.4.5.2. Competitive Scenario
                            11.4.5.3. Regulatory Framework
                            11.4.5.4. Italy Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.6. Spain
                            11.4.6.1. Key Country Dynamics
                            11.4.6.2. Competitive Scenario
                            11.4.6.3. Regulatory Framework
                            11.4.6.4. Spain Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.7. Denmark
                            11.4.7.1. Key Country Dynamics
                            11.4.7.2. Competitive Scenario
                            11.4.7.3. Regulatory Framework
                            11.4.7.4. Denmark Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.8. Sweden
                            11.4.8.1. Key Country Dynamics
                            11.4.8.2. Competitive Scenario
                            11.4.8.3. Regulatory Framework
                            11.4.8.4. Sweden Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.4.9. Norway
                            11.4.9.1. Key Country Dynamics
                            11.4.9.2. Competitive Scenario
                            11.4.9.3. Regulatory Framework
                            11.4.9.4. Norway Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    11.5. Asia Pacific
                        11.5.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.2. Japan
                            11.5.2.1. Key Country Dynamics
                            11.5.2.2. Competitive Scenario
                            11.5.2.3. Regulatory Framework
                            11.5.2.4. Japan Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.3. China
                            11.5.3.1. Key Country Dynamics
                            11.5.3.2. Competitive Scenario
                            11.5.3.3. Regulatory Framework
                            11.5.3.4. China Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.4. India
                            11.5.4.1. Key Country Dynamics
                            11.5.4.2. Competitive Scenario
                            11.5.4.3. Regulatory Framework
                            11.5.4.4. India Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.5. Australia
                            11.5.5.1. Key Country Dynamics
                            11.5.5.2. Competitive Scenario
                            11.5.5.3. Regulatory Framework
                            11.5.5.4. Australia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.6. Thailand
                            11.5.6.1. Key Country Dynamics
                            11.5.6.2. Competitive Scenario
                            11.5.6.3. Regulatory Framework
                            11.5.6.4. Thailand Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.5.7. South Korea
                            11.5.7.1. Key Country Dynamics
                            11.5.7.2. Competitive Scenario
                            11.5.7.3. Regulatory Framework
                            11.5.7.4. South Korea Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    11.6. Latin America
                        11.6.1. Latin America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.6.2. Brazil
                            11.6.2.1. Key Country Dynamics
                            11.6.2.2. Competitive Scenario
                            11.6.2.3. Regulatory Framework
                            11.6.2.4. Brazil Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.6.3. Argentina
                            11.6.3.1. Key Country Dynamics
                            11.6.3.2. Competitive Scenario
                            11.6.3.3. Regulatory Framework
                            11.6.3.4. Argentina Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    11.7. Middle East & Africa
                        11.7.1. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.7.2. South Africa
                            11.7.2.1. Key Country Dynamics
                            11.7.2.2. Competitive Scenario
                            11.7.2.3. Regulatory Framework
                            11.7.2.4. South Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.7.3. Saudi Arabia
                            11.7.3.1. Key Country Dynamics
                            11.7.3.2. Competitive Scenario
                            11.7.3.3. Regulatory Framework
                            11.7.3.4. Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.7.4. UAE
                            11.7.4.1. Key Country Dynamics
                            11.7.4.2. Competitive Scenario
                            11.7.4.3. Regulatory Framework
                            11.7.4.4. UAE Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        11.7.5. Kuwait
                            11.7.5.1. Key Country Dynamics
                            11.7.5.2. Competitive Scenario
                            11.7.5.3. Regulatory Framework
                            11.7.5.4. Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 12. Competitive Landscape
                    12.1. Company Categorization
                        12.1.1. Market Leaders
                        12.1.2. Emerging Players
                    12.2. Company Market Share/Assessment Analysis, 2023
                    12.3. Service Heat Map Analysis
                    12.4. Company Profiles
                        12.4.1. Lonza
                            12.4.1.1. Company Overview
                            12.4.1.2. Financial Performance
                            12.4.1.3. Product/Service Benchmarking
                            12.4.1.4. Strategic Initiatives
                        12.4.2. Richter-Helm Biologics
                            12.4.2.1. Company Overview
                            12.4.2.2. Financial Performance
                            12.4.2.3. Product/Service Benchmarking
                            12.4.2.4. Strategic Initiatives
                        12.4.3. Catalent, Inc
                            12.4.3.1. Company Overview
                            12.4.3.2. Financial Performance
                            12.4.3.3. Product/Service Benchmarking
                            12.4.3.4. Strategic Initiatives
                        12.4.4. Aenova Group
                            12.4.4.1. Company Overview
                            12.4.4.2. Financial Performance
                            12.4.4.3. Product/Service Benchmarking
                            12.4.4.4. Strategic Initiatives
                        12.4.5. Boehringer Ingelheim International GmbH
                            12.4.5.1. Company Overview
                            12.4.5.2. Financial Performance
                            12.4.5.3. Product/Service Benchmarking
                            12.4.5.4. Strategic Initiatives
                        12.4.6. Jubilant Pharmova Limited
                            12.4.6.1. Company Overview
                            12.4.6.2. Financial Performance
                            12.4.6.3. Product/Service Benchmarking
                            12.4.6.4. Strategic Initiatives
                        12.4.7. Thermo Fisher Scientific Inc.
                            12.4.7.1. Company Overview
                            12.4.7.2. Financial Performance
                            12.4.7.3. Product/Service Benchmarking
                            12.4.7.4. Strategic Initiatives
                        12.4.8. Recipharm AB.
                            12.4.8.1. Company Overview
                            12.4.8.2. Financial Performance
                            12.4.8.3. Product/Service Benchmarking
                            12.4.8.4. Strategic Initiatives
                        12.4.9. Corden Pharma International
                            12.4.9.1. Company Overview
                            12.4.9.2. Financial Performance
                            12.4.9.3. Product/Service Benchmarking
                            12.4.9.4. Strategic Initiatives
                        12.4.10. Siegfried Holding AG
                            12.4.10.1. Company Overview
                            12.4.10.2. Financial Performance
                            12.4.10.3. Product/Service Benchmarking
                            12.4.10.4. Strategic Initiatives
                        12.4.11. Piramal Pharma Solutions
                            12.4.11.1. Company Overview
                            12.4.11.2. Financial Performance
                            12.4.11.3. Product/Service Benchmarking
                            12.4.11.4. Strategic Initiatives
                        12.4.12. AbbVie Contract Manufacturing
                            12.4.12.1. Company Overview
                            12.4.12.2. Financial Performance
                            12.4.12.3. Product/Service Benchmarking
                            12.4.12.4. Strategic Initiatives
                        12.4.13. Next Pharma AB
                            12.4.13.1. Company Overview
                            12.4.13.2. Financial Performance
                            12.4.13.3. Product/Service Benchmarking
                            12.4.13.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 4 Global Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 5 Global Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 6 Global Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 7 Global Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 8 Global Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 9 Global Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 10 Global Oral Solid Dosage Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
Table 11 North America Oral Solid Dosage Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 12 North America Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 13 North America Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 14 North America Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 15 North America Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 16 North America Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 17 North America Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 18 North America Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 19 U.S. Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 20 U.S. Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 21 U.S. Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 22 U.S. Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 23 U.S. Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 24 U.S. Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 25 U.S. Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 26 Canada Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 27 Canada Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 28 Canada Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 29 Canada Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 30 Canada Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 31 Canada Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 32 Canada Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 33 Mexico Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 34 Mexico Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 35 Mexico Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 36 Mexico Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 37 Mexico Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 38 Mexico Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 39 Mexico Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 40 Europe Oral Solid Dosage Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 41 Europe Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 42 Europe Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 43 Europe Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 44 Europe Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 45 Europe Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 46 Europe Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 47 Europe Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 48 Germany Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 49 Germany Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 50 Germany Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 51 Germany Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 52 Germany Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 53 Germany Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 54 Germany Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 55 UK Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 56 UK Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 57 UK Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 58 UK Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 59 UK Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 60 UK Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 61 UK Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 62 France Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 63 France Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 64 France Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 65 France Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 66 France Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 67 France Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 68 France Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 69 Italy Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 70 Italy Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 71 Italy Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 72 Italy Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 73 Italy Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 74 Italy Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 75 Italy Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 76 Spain Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 77 Spain Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 78 Spain Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 79 Spain Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 80 Spain Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 81 Spain Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 82 Spain Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 83 Denmark Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 84 Denmark Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 85 Denmark Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 86 Denmark Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 87 Denmark Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 88 Denmark Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 89 Denmark Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 90 Sweden Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 91 Sweden Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 92 Sweden Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 93 Sweden Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 94 Sweden Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 95 Sweden Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 96 Sweden Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 97 Norway Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 98 Norway Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 99 Norway Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 100 Norway Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 101 Norway Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 102 Norway Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 103 Norway Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 104 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 105 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 106 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 107 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 108 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 109 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 110 Asia Pacific Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 111 Asia Pacific Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 112 China Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 113 China Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 114 China Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 115 China Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 116 China Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 117 China Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 118 China Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 119 Japan Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 120 Japan Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 121 Japan Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 122 Japan Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 123 Japan Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 124 Japan Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 125 Japan Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 126 India Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 127 India Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 128 India Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 129 India Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 130 India Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 131 India Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 132 India Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 133 South Korea Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 134 South Korea Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 135 South Korea Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 136 South Korea Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 137 South Korea Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 138 South Korea Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 139 South Korea Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 140 Australia Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 141 Australia Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 142 Australia Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 143 Australia Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 144 Australia Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 145 Australia Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 146 Australia Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 147 Thailand Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 148 Thailand Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 149 Thailand Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 150 Thailand Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 151 Thailand Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 152 Thailand Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 153 Thailand Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 154 Latin America Oral Solid Dosage Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 155 Latin America Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 156 Latin America Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 157 Latin America Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 158 Latin America Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 159 Latin America Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 160 Latin America Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 161 Latin America Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 162 Brazil Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 163 Brazil Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 164 Brazil Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 165 Brazil Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 166 Brazil Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 167 Brazil Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 168 Brazil Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 169 Argentina Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 170 Argentina Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 171 Argentina Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 172 Argentina Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 173 Argentina Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 174 Argentina Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 175 Argentina Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 176 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 177 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 178 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 179 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 180 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 181 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 182 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 183 Middle East & Africa Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 184 South Africa Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 185 South Africa Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 186 South Africa Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 187 South Africa Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 188 South Africa Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 189 South Africa Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 190 South Africa Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 191 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 192 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 193 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 194 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 195 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 196 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 197 Saudi Arabia Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 198 UAE Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 199 UAE Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 200 UAE Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 201 UAE Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 202 UAE Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 203 UAE Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 204 UAE Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 205 Kuwait Oral Solid Dosage Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 206 Kuwait Oral Solid Dosage Contract Manufacturing, by Mechanism, 2018 - 2030 (USD Million)
Table 207 Kuwait Oral Solid Dosage Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
Table 208 Kuwait Oral Solid Dosage Contract Manufacturing, by Drug Potency, 2018 - 2030 (USD Million)
Table 209 Kuwait Oral Solid Dosage Contract Manufacturing, by Prescription Type, 2018 - 2030 (USD Million)
Table 210 Kuwait Oral Solid Dosage Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 211 Kuwait Oral Solid Dosage Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Oral Solid Dosage Contract Manufacturing, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Oral Solid Dosage Contract Manufacturing, for Tablets, 2018 - 2030 (USD Million)
Fig. 13 Global Oral Solid Dosage Contract Manufacturing, for Compressed Tablets, 2018 - 2030 (USD Million)
Fig. 14 Global Oral Solid Dosage Contract Manufacturing, for Orally Disintegrating Tablets (ODT), 2018 - 2030 (USD Million)
Fig. 15 Global Oral Solid Dosage Contract Manufacturing, for Chewable Tablets, 2018 - 2030 (USD Million)
Fig. 16 Global Oral Solid Dosage Contract Manufacturing, for Bi-layer or Tri-layer Tablets, 2018 - 2030 (USD Million)
Fig. 17 Global Oral Solid Dosage Contract Manufacturing, for Sublingual or Buccal Tablets, 2018 - 2030 (USD Million)
Fig. 18 Global Oral Solid Dosage Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 19 Global Oral Solid Dosage Contract Manufacturing, for Capsules, 2018 - 2030 (USD Million)
Fig. 20 Global Oral Solid Dosage Contract Manufacturing, for Hard Gelatin Capsules, 2018 - 2030 (USD Million)
Fig. 21 Global Oral Solid Dosage Contract Manufacturing, for Soft Gelatin Capsules, 2018 - 2030 (USD Million)
Fig. 22 Global Oral Solid Dosage Contract Manufacturing, for Powders, 2018 - 2030 (USD Million)
Fig. 23 Global Oral Solid Dosage Contract Manufacturing, for Granules, 2018 - 2030 (USD Million)
Fig. 24 Global Oral Solid Dosage Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 25 Global Oral Solid Dosage Contract Manufacturing, for Immediate Release, 2018 - 2030 (USD Million)
Fig. 26 Global Oral Solid Dosage Contract Manufacturing, for Delayed Release, 2018 - 2030 (USD Million)
Fig. 27 Global Oral Solid Dosage Contract Manufacturing, for Controlled Release, 2018 - 2030 (USD Million)
Fig. 28 Global Oral Solid Dosage Contract Manufacturing, for Drug Product Development, 2018 - 2030 (USD Million)
Fig. 29 Global Oral Solid Dosage Contract Manufacturing, for Fill Finish Product Manufacturing, 2018 - 2030 (USD Million)
Fig. 30 Global Oral Solid Dosage Contract Manufacturing, for API Manufacturing, 2018 - 2030 (USD Million)
Fig. 31 Global Oral Solid Dosage Contract Manufacturing, for Packaging and Labelling, 2018 - 2030 (USD Million)
Fig. 32 Global Oral Solid Dosage Contract Manufacturing, for Other Applications, 2018 - 2030 (USD Million)
Fig. 33 Global Oral Solid Dosage Contract Manufacturing, for High Potent Drugs, 2018 - 2030 (USD Million)
Fig. 34 Global Oral Solid Dosage Contract Manufacturing, for Moderate Potent Drugs, 2018 - 2030 (USD Million)
Fig. 35 Global Oral Solid Dosage Contract Manufacturing, for Low Potent Drugs, 2018 - 2030 (USD Million)
Fig. 36 Global Oral Solid Dosage Contract Manufacturing, for Prescription Drugs, 2018 - 2030 (USD Million)
Fig. 37 Global Oral Solid Dosage Contract Manufacturing, for Over-The-Counter Drugs, 2018 - 2030 (USD Million)
Fig. 38 Global Oral Solid Dosage Contract Manufacturing, for Oncology, 2018 - 2030 (USD Million)
Fig. 39 Global Oral Solid Dosage Contract Manufacturing, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
Fig. 40 Global Oral Solid Dosage Contract Manufacturing, for Metabolic Disorders, 2018 - 2030 (USD Million)
Fig. 41 Global Oral Solid Dosage Contract Manufacturing, for Neurological Disorders, 2018 - 2030 (USD Million)
Fig. 42 Global Oral Solid Dosage Contract Manufacturing, for Infectious Diseases, 2018 - 2030 (USD Million)
Fig. 43 Global Oral Solid Dosage Contract Manufacturing, for Gastrointestinal Diseases, 2018 - 2030 (USD Million)
Fig. 44 Global Oral Solid Dosage Contract Manufacturing, for Other Therapeutic Areas, 2018 - 2030 (USD Million)
Fig. 45 Global Oral Solid Dosage Contract Manufacturing, for Large Size Companies, 2018 - 2030 (USD Million)
Fig. 46 Global Oral Solid Dosage Contract Manufacturing, for Medium & Small Size Companies, 2018 - 2030 (USD Million)
Fig. 47 Global Oral Solid Dosage Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 48 Regional Outlook, 2023 & 2030
Fig. 49 North America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Canada Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Germany Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 UK Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 France Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Denmark Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Sweden Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Norway Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Japan Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 China Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 India Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Australia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 75 UAE Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)